ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HUMA
#3068
Humacyte, Inc. Common Stock
1.1
2
-6.67%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
-6.67%
月次変化
+7.69%
6か月変化
-28.66%
1年の変化
-66.06%
以前の終値
1.2
0
Open
1.1
2
Bid
Ask
Low
1.1
2
High
1.1
2
ボリューム
61
マーケット
株
ヘルスケア
HUMA
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
12.86 M
103 M
103.33 M
119.08 M
155.12 M
—
Valuation ratios
Enterprise value
—
529.28 M
68.25 M
263.7 M
738.41 M
1.54 B
Price to earnings ratio
—
-10.98
-17.58
-2.7
-4.01
-18.69
Price to sales ratio
—
222.91
138.94
—
149.58 K
—
Price to cash flow ratio
—
3.57
3.06
4.08
6.1
13.08
Price to book ratio
—
2.37
1.86
22.06
11.36
16.39
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
0.09
0.06
0.86
1.08
0.86
Return on equity %
—
0.22
0.1
8.18
2.82
14.46
Return on invested capital %
—
406.93
562.3
737.13
646.28
477.43
Gross margin %
—
100
100
—
100
—
Operating margin %
—
6 246.77
5 405.75
—
2.86 M
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
2 038.46
764.54
—
3.72 M
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.02
20.75
7.88
4.52
2.4
10.15
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0.01
0.01
0
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.1
0.1
0.3
0.46
1.53
Long term debt to total equity ratio
—
0.22
0.17
2.85
1.2
23.11
Per share metrics
Operating cash flow per share
—
2.03
0.69
0.71
0.83
0.76
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
5.64
1.47
0.78
0.38
1.22
Net current asset value per share
—
5.74
1.5
0.81
0.4
1.56
Tangible book value per share
—
3.06
1.13
0.13
0.44
0.77
Working capital per share
—
5.46
1.31
0.63
0.24
0.94
Book value per share
—
3.06
1.13
0.13
0.44
0.77
ニュース
Humacyte, Inc. (HUMA) Falls More Steeply Than Broader Market: What Investors Need to Know
BTIG mantém recomendação de Compra para ações da Humacyte após notícia de financiamento do DoD
BTIG reiterates Buy rating on Humacyte stock amid DoD funding news
Ações da Humacyte disparam após garantir financiamento do DoD para tecnologia de reparo vascular
Humacyte stock jumps after securing DoD funding for vascular repair tech
DoD aloca fundos para tecnologia de reparo vascular bioengenheirada no orçamento de 2026
DoD allocates funds for bioengineered vascular repair tech in 2026 budget
Humacyte, Inc. (HUMA) Exceeds Market Returns: Some Facts to Consider
Benchmark reduz preço-alvo das ações da Humacyte para US$ 10 devido aos planos de registro em Israel
Benchmark lowers Humacyte stock price target to $10 on Israel filing plans
Is Humacyte, Inc. (HUMA) Outperforming Other Medical Stocks This Year?
Humacyte plans to seek approval for vessel product in Israel